Utrecht Biofabrication Facility, Utrecht University, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Lab Chip. 2017 Aug 8;17(16):2785-2792. doi: 10.1039/c7lc00202e.
Arterial thrombosis is the main instigating factor of heart attacks and strokes, which result in over 14 million deaths worldwide every year. The mechanism of thrombosis involves factors from the blood and the vessel wall, and it also relies strongly on 3D vessel geometry and local blood flow patterns. Microfluidic chip-based vascular models allow controlled in vitro studies of the interaction between vessel wall and blood in thrombosis, but until now, they could not fully recapitulate the 3D geometry and blood flow patterns of real-life healthy or diseased arteries. Here we present a method for fabricating microfluidic chips containing miniaturized vascular structures that closely mimic architectures found in both healthy and stenotic blood vessels. By applying stereolithography (SLA) 3D printing of computed tomography angiography (CTA) data, 3D vessel constructs were produced with diameters of 400 μm, and resolution as low as 25 μm. The 3D-printed templates in turn were used as moulds for polydimethylsiloxane (PDMS)-based soft lithography to create microfluidic chips containing miniaturized replicates of in vivo vessel geometries. By applying computational fluid dynamics (CFD) modeling a correlation in terms of flow fields and local wall shear rate was found between the original and miniaturized artery. The walls of the microfluidic chips were coated with human umbilical vein endothelial cells (HUVECs) which formed a confluent monolayer as confirmed by confocal fluorescence microscopy. The endothelialised microfluidic devices, with healthy and stenotic geometries, were perfused with human whole blood with fluorescently labeled platelets at physiologically relevant shear rates. After 15 minutes of perfusion the healthy geometries showed no sign of thrombosis, while the stenotic geometries did induce thrombosis at and downstream of the stenotic area. Overall, the novel methodology reported here, overcomes important design limitations found in typical 2D wafer-based soft lithography microfabrication techniques and shows great potential for controlled studies of the role of 3D vessel geometries and blood flow patterns in arterial thrombosis.
动脉血栓形成是心脏病发作和中风的主要诱因,每年导致全球超过 1400 万人死亡。血栓形成的机制涉及血液和血管壁的因素,也强烈依赖于三维血管几何形状和局部血流模式。基于微流控芯片的血管模型允许在体外控制研究血栓形成中血管壁和血液之间的相互作用,但到目前为止,它们还不能完全再现真实健康或患病动脉的三维几何形状和血流模式。在这里,我们提出了一种制造包含微型血管结构的微流控芯片的方法,这些微型血管结构可以很好地模拟健康和狭窄血管中发现的结构。通过应用计算机断层血管造影术(CTA)数据的立体光刻(SLA)3D 打印,制造出直径为 400μm、分辨率低至 25μm 的 3D 血管结构。3D 打印模板反过来又用作聚二甲基硅氧烷(PDMS)基软光刻的模具,以创建包含体内血管几何结构微型复制品的微流控芯片。通过应用计算流体动力学(CFD)建模,在原始和微型动脉之间发现了流场和局部壁面剪切率之间的相关性。微流控芯片的壁用人类脐静脉内皮细胞(HUVEC)进行了涂层,通过共聚焦荧光显微镜证实了这些细胞形成了一个融合的单层。用荧光标记的血小板以生理相关的剪切率在健康和狭窄的几何形状下对内皮化的微流控装置进行全血灌注。灌注 15 分钟后,健康的几何形状没有血栓形成的迹象,而狭窄的几何形状在狭窄区域及其下游确实会引起血栓形成。总体而言,这里报道的新方法克服了典型的基于 2D 晶圆的软光刻微制造技术中发现的重要设计限制,并显示出在动脉血栓形成中控制三维血管几何形状和血流模式的作用的巨大潜力。